\
&
Contact us
\
&
Contact us
Published on | 5 months ago
ProgrammesThe results of the 2025 European Research Council (ERC) Consolidator Grant call (call deadline 14 January 2025) were published. Consolidator Grants are open to researchers with 7-12 years of experience since completion of PhD (extensions are possible under certain documented circumstances), a scientific track record showing great promise and an excellent research proposal.
Proposals are evaluated in 28 evaluation panels in three research domains (Physical Sciences and Engineering, Social Sciences and Humanities and Life Sciences) composed of top scientists and scholars coming from all over the world and in addition by remote referees with necessary specialised expertise (two to five per proposal).
Of the 3121 submitted proposals 349 researchers with 44 different nationalities received an ERC Consolidator Grant: 93 In Life Sciences, 141 in Physical Sciences and Engineering and 115 in Social Sciences and Humanities. In the ERCEA news articles more background on the evaluation results, call statistics and several project examples are highlighted.
Among the 349 selected researchers are nine based at Flemish host institutions. The projects of these nine Principal Investigators (PIs) are presented in the news articles of Universiteit Gent, KU Leuven, Vrije Universiteit Brussel and imec.
Isabel Beets, KU Leuven, NEUROPEPTALK - Functional Coding of Neuropeptide Signaling Networks in Learning, panel Life Sciences 5
Frederik Dhondt, Vrije Universiteit Brussel, TREATYLAB - The Labyrinth of Treaties, 1712-1763. International Law Behind the Scenes of Early Enlightenment Diplomacy, panel Social Sciences and Humanities 2
Thomas Jagau, KU Leuven, UNBOUND TWO - Theory of nonradiative decay with two or more electrons at play, panel Physical Sciences and Engineering 4
Jonathan Leliaert, Universiteit Gent, THERMAGINE - Engineering thermal (in)stability in heteromagnetic nanostructures, panel Physical Sciences and Engineering 11
Ine Lentacker, Universiteit Gent, My-NANO - Advancing NANOmedicines to rewire tumoral MYeloid cells for next-generation cancer immunotherapies, panel Life Sciences 7
Anton Potocnik, IMEC, SuperQold - Scalable superconducting Qubit readout with millikelvin detection, panel Physical Sciences and Engineering 7
Yentl Swolfs, KU Leuven, CRACKAR - Off-axis crack arrest by harnessing micro- and mesostructural design, panel Physical Sciences and Engineering 11
Nele Vandersickel, Universiteit Gent, TOPOHEART - Topology for understanding the paired nature of cardiac arrhythmia, panel Life Sciences 7
Sarah Verhulst, Universiteit Gent, InSilicoEars - Unlocking bio-inspired machine hearing and accelerating personalized hearing technologies, panel Physical Sciences and Engineering 7
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
